Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBAXBaxter International
FinDog View：Neutral
GILDGilead Sciences
FinDog View：Neutral
| Metric | BAX | GILD |
|---|
| Close | 23.53 | 147.68 |
| Market Cap | $12.2B | $183B |
| 1M | −9.19% | +6.31% |
| P/E (TTM) | — | — |
| Forward P/E | 13.6 | 25.3 |
| P/E 5-Yr Percentile | — | — |
| P/S | 1.1 | 6.0 |
| P/B | 2.0 | 15.3 |
| Dividend Yield | 3.22% | 3.98% |
| Latest Quarter Revenue | $3.0B | $7.8B |
| Revenue YoY | +5.3% | +10.2% |
| Gross Margin | 34.9% | 79.8% |
| Latest Quarter EPS | 0.24 | -8.45 |
| Avg Post-Earnings Move | ±2.5% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.51% | 3.01% |
| 90-Day Net Insider Buying | — | −$15.4M |
BAX · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
